In the latest session, Pulmonx Corporation (NASDAQ: LUNG) closed at $8.78 up 1.39% from its previous closing price of $8.66. In other words, the price has increased by $+0.12 from its previous closing price. On the day, 797707 shares were traded. LUNG stock price reached its highest trading level at $8.90 during the session, while it also had its lowest trading level at $8.48.
For a deeper understanding of Pulmonx Corporation’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.70 and its Current Ratio is at 8.40. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
On December 12, 2022, Citigroup Upgraded its rating to Buy which previously was Neutral and also lowered its target price recommendation from $14 to $10.
Citigroup Downgraded its Buy to Neutral on July 11, 2022, whereas the target price for the stock was revised from $23 to $19.
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 01 when Sung Derrick sold 1,069 shares for $5.93 per share. The transaction valued at 6,339 led to the insider holds 262,746 shares of the business.
French Glendon E. III sold 3,631 shares of LUNG for $21,532 on Dec 01. The President and CEO now owns 1,034,313 shares after completing the transaction at $5.93 per share. On Dec 01, another insider, Lehman David Aaron, who serves as the General Counsel of the company, sold 1,069 shares for $5.93 each. As a result, the insider received 6,339 and left with 44,160 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.28 while its Price-to-Book (P/B) ratio in mrq is 2.00.
Stock Price History:
Over the past 52 weeks, LUNG has reached a high of $29.25, while it has fallen to a 52-week low of $4.07. The 50-Day Moving Average of the stock is 6.95, while the 200-Day Moving Average is calculated to be 15.56.
For the past three months, LUNG has traded an average of 695.32K shares per day and 340.2k over the past ten days. A total of 37.19M shares are outstanding, with a floating share count of 36.03M. Shares short for LUNG as of Oct 13, 2022 were 3.73M with a Short Ratio of 2.82M, compared to 3.33M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 10.01% and a Short% of Float of 12.60%.
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.4 for the current quarter, with a high estimate of -$0.36 and a low estimate of -$0.44, while EPS last year was -$0.28. The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.37 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$1.59 and -$1.72 for the fiscal current year, implying an average EPS of -$1.62. EPS for the following year is -$1.34, with 7 analysts recommending between -$1.23 and -$1.5.
A total of 4 analysts believe the company’s revenue will be $14.92M this quarter.It ranges from a high estimate of $15.2M to a low estimate of $14.62M. As of the current estimate, Pulmonx Corporation’s year-ago sales were $13.26M, an estimated increase of 12.50% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $17.86M, an increase of 30.30% over than the figure of $12.50% in the same quarter last year. There is a high estimate of $18.21M for the next quarter, whereas the lowest estimate is $17.65M.
A total of 6 analysts have provided revenue estimates for LUNG’s current fiscal year. The highest revenue estimate was $57.79M, while the lowest revenue estimate was $57.01M, resulting in an average revenue estimate of $57.47M. In the same quarter a year ago, actual revenue was $48.42M, up 18.70% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $80.05M in the next fiscal year. The high estimate is $84.1M and the low estimate is $74.8M. The average revenue growth estimate for next year is up 39.30% from the average revenue estimate for this year.